Person:

Acharya, Sanket S.

Loading...
Profile Picture

Email Address

AA Acceptance Date

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

Acharya

First Name

Sanket S.

Name

Acharya, Sanket S.

Search Results

Now showing 1 - 2 of 2
  • Publication

    Inhibiting stromal cell heparan sulfate synthesis improves stem cell mobilization and enables engraftment without cytotoxic conditioning

    (American Society of Hematology, 2014) Saez, Borja; Ferraro, F.; Yusuf, Rushdia; Cook, Colleen M.; Yu, Vionnie Wing Chi; Pardo-Saganta, A.; Sykes, Stephen M.; Palchaudhuri, Rahul; Schajnovitz, Amir; Lotinun, Sutada; Lymperi, Stefania; Mendez-Ferrer, Simon; del Toro, Raquel; Day, Robyn; Vasic, Radovan; Acharya, Sanket S.; Baron, Roland; Lin, Charles; Yamaguchi, Yu; Wagers, Amy; Scadden, David

    The glycosyltransferase gene, Ext1, is essential for heparan sulfate production. Induced deletion of Ext1 selectively in Mx1-expressing bone marrow (BM) stromal cells, a known population of skeletal stem/progenitor cells, in adult mice resulted in marked changes in hematopoietic stemand progenitor cell (HSPC) localization.HSPCegressed fromBMto spleen after Ext1 deletion. This was associated with altered signaling in the stromal cells and with reduced vascular cell adhesion molecule 1 production by them. Further, pharmacologic inhibition of heparan sulfate mobilized qualitatively more potent and quantitatively more HSPC from the BM than granulocyte colony-stimulating factor alone, including in a setting of granulocyte colony-stimulating factor resistance. The reduced presence of endogenous HSPC after Ext1 deletion was associated with engraftment of transfused HSPC without any toxic conditioning of the host. Therefore, inhibiting heparan sulfate production may provide a means for avoiding the toxicities of radiation or chemotherapy in HSPC transplantation for nonmalignant conditions. (Blood. 2014;124(19):2937-2947).

  • Publication

    Phosphatases and microRNAs: Investigations in the Context of DNA Damage

    (2016-01-22) Acharya, Sanket S.; Novina, Carl; Zou, Lee; Durocher, Daniel

    Integrity of the cellular genome is constantly threatened by various sources of DNA damage that cause a variety of lesions including double strand breaks. Cells respond to such insults by upregulating the DNA damage response, a carefully orchestrated set of molecular events that leads to transcriptional changes, cell cycle arrest and/or apoptosis. In this dissertation we provide evidence supporting a role for phosphatases and microRNAs (miRNAs) in the cellular response to DNA damage.

    53BP1 (tumor suppressor p53 binding protein 1) is a critical mediator of DNA repair signaling and its activity is regulated by several post-translational modifications. Here we show that 53BP1 is phosphorylated during mitosis on two residues, T1609 and S1618, located in the ubiquitination-dependent recruitment motif. These residues are dephosphorylated in late mitosis/early G1 by the PP4C/R3β phosphatase complex, which is required for 53BP1 accumulation at DNA breaks. We discovered that R3β preferentially interacts with 53BP1 in stalled mitosis and determined that this interaction is dependent on the phosphorylation of R3β residue S840 by the cyclin-dependent kinase family member CDK5. We also found that 53BP1 is deliberately excluded from chromatin during mitosis to prevent genomic instability. Ectopic reactivation of 53BP1 in mitosis causes increased micronuclei and lagging chromosome formation, which can be partially reversed by inhibiting the non-homologous end-joining pathway.

    In a more clinical scenario, accidental radiation exposure can cause DNA damage that manifests itself in complex malignancies including bone marrow failure and cancer. In order to accurately predict radiation exposure for better management of radiation accidents, we identified serum microRNA (miRNA) signatures capable of indicating the long-term impact of total body irradiation in animals. Using different doses of radiation we systematically studied the impact of TBI on the hematopoietic system and then identified three miRNA signatures that effectively distinguished between animals exposed to control, sublethal, and lethal radiation. Furthermore, we used radioprotective and radiomitigating agents to show that serum miRNAs can predict not only the dose of radiation but also its impact on animal health. Finally, to investigate the relevance of these miRNAs in humans, we validated our findings in a humanized mouse model.